Abstract | PURPOSE: METHODS: RESULTS: Follow up ranged between 3 and 6 months (mean 4.2 +/- 1.23 months). Improvement of vision was observed after one week with BCVA improved to 0.47 +/- 0.26 compared with baseline BCVA of 0.365 +/- 0.26 (P < 0.05). At last follow up, BCVA was 0.65 +/- 0.33. Seven eyes had better visual acuity. Vitreous hemorrhage cleared completely in 4 eyes while 2 eyes had residual vitreous hemorrhage. Regression of retinal neovascularization was complete in 7 eyes, incomplete in 3 eyes. Regression was observed as early as 2 weeks after first injection. Reperfusion after regression was observed in 2 eyes. Patients received a mean of 1.7 +/- 0.67 injections per eye. No complications were noted in all eyes. Pancryopexy was done in 1 eye and additional laser was done in 2 eyes. CONCLUSION: SUMMARY:
|
Authors | Ashraf M El-Batarny |
Journal | Clinical ophthalmology (Auckland, N.Z.)
(Clin Ophthalmol)
Vol. 1
Issue 2
Pg. 149-55
(Jun 2007)
ISSN: 1177-5467 [Print] New Zealand |
PMID | 19668504
(Publication Type: Journal Article)
|